MRI to Predict Nipple Involvement in Breast Cancer Patients

Carregando...
Imagem de Miniatura
Citações na Scopus
23
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER ROENTGEN RAY SOC
Citação
AMERICAN JOURNAL OF ROENTGENOLOGY, v.206, n.5, p.1124-1130, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE. The selection of breast cancer patients as candidates for nipple-sparing mastectomy (NSM) is dependent on the preoperative detection of neoplastic involvement of the nipple-areola complex (NAC). This cross-sectional study was designed to evaluate the accuracy of preoperative breast MRI as a noninvasive method to predict neoplastic involvement of the nipple. MATERIALS AND METHODS. We included 165 female breast cancer patients with a surgical plan that included total mastectomy or breast conservation surgery with the removal of the NAC. All patients underwent MRI before surgery on a 1.5-T unit with a 4-channel in vivo dedicated surface breast coil. One radiologist who was blinded to the results of the histologic evaluations of the specimens evaluated the MRI studies. RESULTS. Of the 170 mastectomy specimens evaluated, 37 (21.8%) had neoplastic involvement of the NAC. The MRI findings of enhancement between the index lesion and the NAC and of nipple retraction were considered statistically significant predictors of nipple involvement in breast cancer patients (p < 0.01 and p = 0.01, respectively). The negative predictive value of the combination of these MRI findings was 83.3%. CONCLUSION. Breast MRI is a safe noninvasive method to preoperatively evaluate breast cancer patients eligible for NSM with a high specificity and a high negative predictive value when enhancement between the index lesion and the nipple and nipple retraction are analyzed.
Palavras-chave
breast cancer, MRI, nipple involvement prediction
Referências
  1. Sakamoto N, 2013, BREAST CANCER-TOKYO, V20, P316, DOI 10.1007/s12282-012-0338-1
  2. Jensen JA, 2011, ANN SURG ONCOL, V18, P1665, DOI 10.1245/s10434-010-1475-4
  3. Caruso F, 2006, EJSO-EUR J SURG ONC, V32, P937, DOI 10.1016/j.ejso.2006.05.013
  4. Chagpar AB, 2004, AM SURGEON, V70, P425
  5. Ponzone R, 2015, EUR J CANCER, V51, P1882, DOI 10.1016/j.ejca.2015.07.001
  6. Petit JY, 2003, TUMORI, V89, P288
  7. Kneubil MC, 2012, ANN SURG ONCOL, V19, P4117, DOI 10.1245/s10434-012-2514-0
  8. Carlson GW, 1996, AM SURGEON, V62, P151
  9. Sacchini V, 2006, J AM COLL SURGEONS, V203, P704, DOI 10.1016/j.jamcollsurg.2006.07.015
  10. SANTINI D, 1989, AM J SURG, V158, P399, DOI 10.1016/0002-9610(89)90272-9
  11. Moon JY, 2013, AM J ROENTGENOL, V201, P448, DOI 10.2214/AJR.12.9186
  12. Gerber B, 2003, ANN SURG, V238, P120, DOI 10.1097/01.SLA.0000077922.38307.cd
  13. LAGIOS MD, 1979, AM J SURG, V138, P135, DOI 10.1016/0002-9610(79)90253-8
  14. Simmons RM, 2002, ANN SURG ONCOL, V9, P165
  15. Brachtel EF, 2009, J CLIN ONCOL, V27, P4948, DOI 10.1200/JCO.2008.20.8785
  16. Garcia-Etienne CA, 2009, BREAST J, V15, P440, DOI 10.1111/j.1524-4741.2009.00758.x
  17. Petit JY, 2009, BREAST CANCER RES TR, V117, P333, DOI 10.1007/s10549-008-0304-y
  18. Govindarajulu S, 2006, EJSO, V32, P410, DOI 10.1016/j.ejso.2006.01.013
  19. LUTTGES J, 1987, J CANCER RES CLIN, V113, P481, DOI 10.1007/BF00390043
  20. Benediktsson KP, 2008, EJSO-EUR J SURG ONC, V34, P143, DOI 10.1016/j.ejso.2007.06.010
  21. Babiera G, 2010, ANN SURG ONCOL, V17, pS245, DOI 10.1245/s10434-010-1256-0
  22. Byon W, 2014, J BREAST CANCER, V17, P386, DOI 10.4048/jbc.2014.17.4.386
  23. de Alcantara FP, 2011, ANN SURG ONCOL, V18, P3117, DOI 10.1245/S10434-011-1974-Y
  24. Eisenberg REK, 2014, BREAST J, V20, P15, DOI 10.1111/tbj.12199
  25. Endara M, 2013, PLAST RECONSTR SURG, V132, P1043, DOI 10.1097/PRS.0b013e3182a48b8a
  26. Lohsiriwat Visnu, 2012, Gland Surg, V1, P75, DOI 10.3978/j.issn.2227-684X.2012.06.02
  27. Morales Piato JR, 2015, EUR J SURG ONCOL, V41, P986